Piper Jaffray Starts Aptevo Therapeutics (APVO) at Overweight
Get Alerts APVO Hot Sheet
Price: $4.26 +4.93%
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 13 | Down: 10 | New: 11
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 13 | Down: 10 | New: 11
Join SI Premium – FREE
Piper Jaffray earlier initiated coverage on Aptevo Therapeutics (NASDAQ: APVO) with an Overweight rating and a price target of $7.00.
For an analyst ratings summary and ratings history on Aptevo Therapeutics click here. For more ratings news on Aptevo Therapeutics click here.
Shares of Aptevo Therapeutics closed at $2.20 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TD Cowen Starts Grindr (GRND) at Buy
- William Blair Starts Solid Biosciences (SLDB) at Outperform, 'success in any of programs alone should provide severalfold upside from Solid’s current valuation'
- Barclays Starts Elia Group SA (ELI:BB) at Overweight
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!